Rituximab in the treatment of refractory pulmonary sarcoidosis.
作者信息
Sweiss Nadera J, Lower Elyse E, Mirsaeidi Mehdi, Dudek Steven, Garcia Joe G N, Perkins David, Finn Patricia W, Baughman Robert P
机构信息
Chicago, IL.
出版信息
Eur Respir J. 2014 May;43(5):1525-8. doi: 10.1183/09031936.00224513. Epub 2014 Jan 31.
Abstract
摘要
相似文献
1
Rituximab in the treatment of refractory pulmonary sarcoidosis.
Eur Respir J. 2014 May;43(5):1525-8. doi: 10.1183/09031936.00224513. Epub 2014 Jan 31.
2
The treatment of pulmonary sarcoidosis.
Respir Med. 2012 Oct;106(10):1351-61. doi: 10.1016/j.rmed.2012.01.013. Epub 2012 Apr 9.
3
Neurological picture. Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1338-9. doi: 10.1136/jnnp-2013-305456. Epub 2013 Jun 26.
4
Cytokine modulators in the treatment of sarcoidosis.
Rheumatol Int. 2011 Dec;31(12):1539-44. doi: 10.1007/s00296-011-1969-9. Epub 2011 Jun 5.
5
Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
An Bras Dermatol. 2014 Nov-Dec;89(6):980-4. doi: 10.1590/abd1806-4841.20143128.
6
Outcome of the treatment for sarcoidosis.
Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):920-1. doi: 10.1164/ajrccm/151.3_Pt_1.920b.
7
First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus.
Acta Derm Venereol. 2014 Jul;94(4):472-3. doi: 10.2340/00015555-1746.
8
The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2006 Mar;23(1):51-7. doi: 10.1007/s11083-006-9030-4.
9
Corticosteroids in sarcoidosis: friend or foe?
Eur Respir J. 1994 Jul;7(7):1203-9. doi: 10.1183/09031936.94.07071203.
10
[Idiopathic nephrotic syndrome in children: from corticosteroids to rituximab].
Arch Pediatr. 2011 Aug;18(8):843-5. doi: 10.1016/j.arcped.2011.05.019. Epub 2011 Jun 29.
引用本文的文献
1
Cytokine Profiles of Bronchoalveolar Lavage in Patients with Interstitial Lung Diseases and Non-Allergic Asthma.
Int J Mol Sci. 2025 Jul 16;26(14):6831. doi: 10.3390/ijms26146831.
2
Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain.
Int Ophthalmol. 2025 Jun 27;45(1):268. doi: 10.1007/s10792-025-03629-9.
3
Sarcoidosis-Associated Pulmonary Hypertension.
Medicina (Kaunas). 2025 Feb 14;61(2):342. doi: 10.3390/medicina61020342.
4
Sarcoidosis: molecular mechanisms and therapeutic strategies.
Mol Biomed. 2025 Feb 5;6(1):6. doi: 10.1186/s43556-025-00244-z.
5
Sarcoidosis: A Review of the Guidelines and What's To Come.
Mo Med. 2024 Sep-Oct;121(5):373-378.
6
Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases.
J Clin Invest. 2024 Sep 3;134(17):e178711. doi: 10.1172/JCI178711.
7
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease.
Biomedicines. 2024 Jun 21;12(7):1384. doi: 10.3390/biomedicines12071384.
8
Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis.
J Clin Med. 2024 Jan 27;13(3):738. doi: 10.3390/jcm13030738.
9
Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.
J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.
10
Pulmonary Function in Pulmonary Sarcoidosis.
J Clin Med. 2023 Oct 24;12(21):6701. doi: 10.3390/jcm12216701.
本文引用的文献
1
Nonsteroidal therapy of sarcoidosis.
Curr Opin Pulm Med. 2013 Sep;19(5):516-23. doi: 10.1097/MCP.0b013e3283642ad0.
2
Rituximab for refractory granulomatous eye disease.
Clin Ophthalmol. 2012;6:1613-8. doi: 10.2147/OPTH.S35521. Epub 2012 Oct 5.
3
Therapy for sarcoidosis: evidence-based recommendations.
Expert Rev Clin Immunol. 2012 Jan;8(1):95-103. doi: 10.1586/eci.11.84.
4
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry.
Arthritis Care Res (Hoboken). 2012 Mar;64(3):331-9. doi: 10.1002/acr.20689.
5
Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.
Clin Vaccine Immunol. 2011 Aug;18(8):1306-16. doi: 10.1128/CVI.05118-11. Epub 2011 Jun 8.
6
A concise review of pulmonary sarcoidosis.
Am J Respir Crit Care Med. 2011 Mar 1;183(5):573-81. doi: 10.1164/rccm.201006-0865CI. Epub 2010 Oct 29.
7
A case of neurosarcoidosis successfully treated with rituximab.
Neurology. 2010 Aug 10;75(6):568-70. doi: 10.1212/WNL.0b013e3181ec7ff9.
8
Rituximab as a treatment alternative in sarcoidosis.
Joint Bone Spine. 2008 Jul;75(4):511-2. doi: 10.1016/j.jbspin.2008.01.025. Epub 2008 Jun 17.
9
Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
Clin Dermatol. 2007 May-Jun;25(3):341-6. doi: 10.1016/j.clindermatol.2007.03.012.
10
Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation.
Br Med J. 1961 Nov 4;2(5261):1165-72. doi: 10.1136/bmj.2.5261.1165.
Zotero 插件